tradmap

CELU Earnings Celularity Inc

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing

Annual results

Diluted EPS (annual)
-$15 -$7 $1 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $27M $54M 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$208M -$97M $14M $0 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$5 -$2 $1 $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $9M $18M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$94M -$42M $10M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–26 of 26
Q2 20262026-06-300.022026-10-2010-Q
Q1 20262026-03-310.022026-09-2910-Q
Q4 2025 (derived)2025-12-31-0.852026-04-3010-K
FY 20252025-12-31-3.592026-04-3010-K
Q3 20252025-09-30-0.882025-11-1410-Q
Q2 20252025-06-30-1.022025-08-2910-Q
Q1 20252025-03-31-0.842025-08-2910-Q
Q4 2024 (derived)2024-12-31-0.582025-05-0810-K
FY 20242024-12-31-2.642025-05-0810-K
Q3 20242024-09-30-0.732024-12-0610-Q
Q2 20242024-06-30-0.302024-11-0710-Q
Q1 20242024-03-31-1.032024-10-1610-Q
Q4 2023 (derived)2023-12-310.802024-07-3010-K
FY 20232023-12-31-11.022024-07-3010-K
Q3 20232023-09-30-4.982024-01-0310-Q
Q2 20232023-06-30-2.722023-08-1410-Q
Q1 20232023-03-31-4.122023-05-2210-Q
Q4 2022 (derived)2022-12-312.252023-03-3110-K
FY 20222022-12-310.952023-03-3110-K
Q3 20222022-09-300.302022-11-1010-Q
Q2 20222022-06-303.202022-08-0910-Q
Q1 20222022-03-31-4.80——
FY 20212021-12-31-14.90——
Q3 20212021-09-304.002021-11-1210-Q
Q2 20212021-06-30-26.90——
Q3 20202020-09-30-25.20——

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.